Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000538923 | SCV000655220 | benign | Tumor predisposition syndrome 3 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000566783 | SCV000674389 | benign | Hereditary cancer-predisposing syndrome | 2017-01-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000608970 | SCV000730730 | benign | not specified | 2018-01-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Genomic Medicine, |
RCV000608970 | SCV002550165 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000608970 | SCV002773918 | benign | not specified | 2021-06-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004712886 | SCV005267105 | benign | not provided | criteria provided, single submitter | not provided |